Multivessel coronary artery disease: Current revascularization strategies

European Heart Journal

Volumn 22, Issue 14, 2001, Pages 1183-1197

  Patil, Chandrashekhar V ^a   Nikolsky, E ^a   Boulos, M ^a   Grenadier, E ^a   Beyar, R ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Coronary artery bypass surgery; Multivessel coronary artery disease; Multivessel stent implantation; Percutaneous transluminal coronary angioplasty; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; STATIN; TICLOPIDINE;

CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DISEASE SEVERITY; GENE THERAPY; HEALTH CARE COST; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RECOMBINANT GENE; REVIEW; SURGICAL RISK; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS; CORONARY ARTERY BYPASS; CORONARY DISEASE; HUMANS; MYOCARDIAL REVASCULARIZATION; STENTS; SURVIVAL ANALYSIS;

EID: 0034887990     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2497     Document Type: Review

References (132)

1. Aortocoronary bypass with saphenous vein graft Seven-year follow up
2. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris
3. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study
4. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina
5. Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: A Coronary Artery Surgery Study Registry study
6. Survival following coronary artery bypass grafting in patients with severe angina pectoris (CASS): An observational study
7. ACC/AHA guidelines and indications for coronary artery bypass graft surgery
8. Nonoperative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty
9. Effects of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
10. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease
11. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: Outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs cooperative randomized trial
12. Coronary angioplasty versus medical therapy for angina: The Second Randomized Intervention Treatment of Angina (RITA-2) trial
13. The Medicine, Angioplasty, or Surgery Study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending artery stenoses
14. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study two year follow up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization
15. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction less than or equal to forty percent
16. Coronary angioplasty versus coronary bypass: Three-year follow-up of a matched series of 250 patients
17. Comparison of percutaneous transluminal coronary angioplasty versus coronary artery bypass grafting for multivessel coronary artery disease
18. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease
19. Angioplasty versus surgery in multivessel disease: Immediate results and in-hospital outcome in a randomized prospective study
20. Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): In-hospital results and 1-year follow-up
21. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease
22. A randomized trial comparing coronary angioplasty with coronary bypass surgery
23. Coronary angioplasty vs coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) Trial
24. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation)
25. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
26. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease
27. Meta-analysis of randomized trials comparing coronary angioplasty with bypass surgery
28. Health service costs of coronary angioplasty and coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial
29. Coronary angioplasty compared with bypass grafting
30. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial)
31. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: Sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery
32. Five-year changes in coronary arteries of medical and surgical patients of the Veterans Administration randomized study of bypass surgery
33. Management of chronic stable angina: Medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery: Lessons from the randomized trials
34. The degree of revascularization and outcome after multivessel coronary angioplasty
35. Survival of medically treated patients in the coronary artery surgery study (CASS) registry
36. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry
37. The influence of residual disease after coronary bypass on the 5-year survival rate of 1,274 men with coronary artery disease
38. Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry)
39. Immediate and short-term benefit of multilesion coronary angioplasty: Influence of degree of revascularization
40. Degree of revascularization in patients with multivessel coronary disease: A report from the National Heart, Lung, and Blood Institute Percutaneous transluminal Coronary Angioplasty Registry
41. Follow up clinical results in patients undergoing percutaneous transluminal coronary angioplasty
42. Efficacy of percutaneous transluminal coronary angioplasty: Randomized trials of myocardial revascularization
43. Angiographic morphology and the pathogenesis of unstable angina pectoris
44. Percutaneous transluminal coronary angioplasty of the 'culprit lesion' for management of unstable angina pectoris in patients with multivessel coronary artery disease
45. Coronary angioplasty of the unstable angina related vessel in patients with multivessel disease
46. Incidence and follow up of Braunwald subgroups in unstable angina pectoris
47. Risk stratification in unstable angina: Prospective validation of the Braunwald classification
48. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty
49. Immediate outcome following coronary angioplasty. A contemporary single center audit
50. Chronic coronary heart disease
51. Outcome in patients with acute non Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
52. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomized trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease
53. Percutaneous coronary intervention for unstable angina
54. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
55. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial
56. Short and long term outcome of diabetic patients undergoing coronary angioplasty
57. Corollary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
58. Multivessel balloon angioplasty should be abandoned in diabetic patients!
59. Comparison of outcome after coronary angioplasty and coronary surgery for multivessel coronary artery disease in persons with diabetes
60. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty
61. 'Limitless' contrast for coronary angiography?
62. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
63. The ARTS (Arterial Revascularization Therapies Study): Backgrounds, goals and methods
64. Staged versus one-step approach for multivessel percutaneous coronary interventions
65. Multivessel stenting: Staged vs non-staged approach: Perspective: Thoraxcentre, Rotterdam, The Netherlands
66. Medical care costs and quality of life alter randomization to coronary angioplasty or coronary bypass surgery
67. Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty
68. In hospital and one-year economic outcomes after coronary stenting or balloon angioplasty
69. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association task force on the assessment of diagnostic and therapeutic cardiovascular procedures
70. A prospective study of elective stenting in unprotected left main coronary disease
71. Percutaneous transluminal coronary angioplasty: Report from the Registry of the National Heart, Lung, and Blood Institute
72. Left main coronary angioplasty: Early and late results of 127 acute and elective procedures
73. Contemporary percutaneous treatment of unprotected left main coronary stenoses: Initial results from a multicenter registry analysis 1994-1996
74. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience)
75. Left main intervention revisited: Early and late outcome of PTCA and stenting
76. Study on risk factors and late results of coronary artery bypass grafting for acute myocardial infarction
77. Prognosis and management of anterolateral myocardial infarction in patients with severe left main disease and cardiogenic shock. The left main shock syndrome
78. Stenting of unprotected left main coronary artery stenoses: Immediate and late outcomes
79. Stenting of unprotected left main coronary artery stenosis without coumadin
80. Unprotected left main stenting: Preliminary results and follow-up with first 41 patients
81. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
82. A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
83. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries
84. Angiographic and clinical outcome following coronary stenting of small vessels: A comparison with coronary stenting of large vessels
85. A randomized trial of coronary stenting and balloon angioplasty in the treatment of aortocoronary saphenous vein bypass graft disease
86. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty
87. Stenting in Chronic Coronary Occlusion (SICCO): A randomized, controlled trial of adding stent implantation after successful angioplasty
88. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial
89. Coronary angioplasty with or without stent implantation for acute myocardial infarction
90. Stents: Indications and limitations
91. Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting
92. Multivessel Palmaz-Schatz stenting: Early results and one-year outcome
93. Clinical outcome after multivessel coronary stent implantation
94. One-year outcome in multivessel coronary disease patients undergoing coronary stenting
95. Procedural results and late clinical outcomes following multivessel coronary stenting
96. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
97. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
98. Intracoronary radiation therapy for patients with in-stent restenosis: 6 month follow-up of a randomized clinical study
99. Intracoronary gamma radiation for the prevention of recurrent in-stent restenosis: Final results from the Gamma-I Trial
100. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study
101. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: Results of the Beta Energy Restenosis Trial (BERT)
102. 32P): The final report of the PREVENT Trial
103. Intracoronary beta radiation therapy for patients with in-stent restenosis: The 6 months clinical and angiographic results
104. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease
105. Abciximab reduces mortality in diabetics following percutaneous coronary intervention
106. Integrating GP IIb/IIIa inhibitors in management of acute coronary syndromes
107. From research to clinical practice: Current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory
108. Role of intracoronary ultrasound after high-pressure stent implantation
109. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion
110. Twelve year experience with internal mammary artery for coronary artery bypass
111. ACC/AHA guidelines for coronary artery bypass graft surgery
112. Bypass surgery with the internal mammary artery graft: 15 year follow up
113. Results of internal thoracic artery grafting over 15 years: Single versus double grafts
114. Free (aorta-coronary) internal mammary artery graft: Late results
115. The radial artery for coronary artery bypass grafting: Clinical and angiographic results at five years
116. Current perspectives on statins
117. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
118. Cardiovascular drugs: Aspirin
119. A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting
120. Delivery strategies to achieve therapeutic myocardial angiogenesis
121. Myocardial laser revascularization: The controversy and the data
122. Transmyocardial laser revascularization in patients with refractory angina: A randomized controlled trial
123. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
124. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina
125. Transmyocardial laser revascularization
126. Percutaneous myocardial laser revascularization for patients with end-stage coronary artery disease and refractory angina pectoris
127. Percutaneous laser revascularization (PMR) with a holium laser: A pilot multicenter feasibility trial
128. Percutaneous myocardial revascularization in patients with refractory angina
129. Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping
130. Interventional cardiology versus minimally invasive cardiac surgery
131. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction